182 related articles for article (PubMed ID: 38390973)
1. Establishment of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in Saint Petersburg.
Kiselev A; Maretina M; Shtykalova S; Al-Hilal H; Maslyanyuk N; Plokhih M; Serebryakova E; Frolova M; Shved N; Krylova N; Il'ina A; Freund S; Osinovskaya N; Sultanov I; Egorova A; Lobenskaya A; Koroteev A; Sosnina I; Gorelik Y; Bespalova O; Baranov V; Kogan I; Glotov A
Int J Neonatal Screen; 2024 Jan; 10(1):. PubMed ID: 38390973
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Spinal Muscular Atrophy Based on the Results of a Large-Scale Pilot Project on 202,908 Newborns.
Efimova IY; Zinchenko RA; Marakhonov AV; Balinova NV; Mikhalchuk KA; Shchagina OA; Polyakov AV; Mudaeva DA; Saydaeva DH; Matulevich SA; Parshintseva PD; Belyashova EY; Yakubovskiy GI; Tebieva IS; Gabisova YV; Irinina NA; Jamschikova AV; Nurgalieva LR; Saifullina EV; Nevmerzhitskaya KS; Belyaeva TI; Romanova OS; Voronin SV; Kutsev SI
Pediatr Neurol; 2024 Jul; 156():147-154. PubMed ID: 38781723
[TBL] [Abstract][Full Text] [Related]
3. PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan.
Noguchi Y; Bo R; Nishio H; Matsumoto H; Matsui K; Yano Y; Sugawara M; Ueda G; Wijaya YOS; Niba ETE; Shinohara M; Bouike Y; Takeuchi A; Okamoto K; Saito T; Shimomura H; Lee T; Takeshima Y; Iijima K; Nozu K; Awano H
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421785
[TBL] [Abstract][Full Text] [Related]
4. Newborn screening for spinal muscular atrophy: The Wisconsin first year experience.
Baker MW; Mochal ST; Dawe SJ; Wiberley-Bradford AE; Cogley MF; Zeitler BR; Piro ZD; Harmelink MM; Kwon JM
Neuromuscul Disord; 2022 Feb; 32(2):135-141. PubMed ID: 35120759
[TBL] [Abstract][Full Text] [Related]
5. Pilot Study on Newborn Screening for Spinal Muscular Atrophy.
Fonseca H; Ribeiro D; Guimarães F; Pinto C; Marcão A; Sousa C; Carvalho I; Lopes L; Rodrigues D; Rocha H; Vilarinho L
Endocr Metab Immune Disord Drug Targets; 2023 Sep; ():. PubMed ID: 37711122
[TBL] [Abstract][Full Text] [Related]
6. Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening.
Chien YH; Chiang SC; Weng WC; Lee NC; Lin CJ; Hsieh WS; Lee WT; Jong YJ; Ko TM; Hwu WL
J Pediatr; 2017 Nov; 190():124-129.e1. PubMed ID: 28711173
[TBL] [Abstract][Full Text] [Related]
7. Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy.
Vidal-Folch N; Gavrilov D; Raymond K; Rinaldo P; Tortorelli S; Matern D; Oglesbee D
Clin Chem; 2018 Dec; 64(12):1753-1761. PubMed ID: 30352867
[TBL] [Abstract][Full Text] [Related]
8. Pilot Program of Newborn Screening for 5q Spinal Muscular Atrophy in the Russian Federation.
Mikhalchuk K; Shchagina O; Chukhrova A; Zabnenkova V; Chausova P; Ryadninskaya N; Vlodavets D; Kutsev SI; Polyakov A
Int J Neonatal Screen; 2023 May; 9(2):. PubMed ID: 37218894
[TBL] [Abstract][Full Text] [Related]
9. Validation of a Fast, Robust, Inexpensive, Two-Tiered Neonatal Screening Test algorithm on Dried Blood Spots for Spinal Muscular Atrophy.
Strunk A; Abbes A; Stuitje AR; Hettinga C; Sepers EM; Snetselaar R; Schouten J; Asselman FL; Cuppen I; Lemmink H; van der Pol WL; Engel H
Int J Neonatal Screen; 2019 Jun; 5(2):21. PubMed ID: 33072980
[TBL] [Abstract][Full Text] [Related]
10. Genetic screening of spinal muscular atrophy using a real-time modified COP-PCR technique with dried blood-spot DNA.
Ar Rochmah M; Harahap NIF; Niba ETE; Nakanishi K; Awano H; Morioka I; Iijima K; Saito T; Saito K; Lai PS; Takeshima Y; Takeuchi A; Bouike Y; Okamoto M; Nishio H; Shinohara M
Brain Dev; 2017 Oct; 39(9):774-782. PubMed ID: 28522225
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Spinal Muscular Atrophy Carrier Status by Determining
Wijaya YOS; Purevsuren J; Harahap NIF; Niba ETE; Bouike Y; Nurputra DK; Rochmah MA; Thursina C; Hapsara S; Yamaguchi S; Nishio H; Shinohara M
Int J Neonatal Screen; 2020 Jun; 6(2):43. PubMed ID: 33073034
[TBL] [Abstract][Full Text] [Related]
12. One Year of Newborn Screening for SMA - Results of a German Pilot Project.
Vill K; Kölbel H; Schwartz O; Blaschek A; Olgemöller B; Harms E; Burggraf S; Röschinger W; Durner J; Gläser D; Nennstiel U; Wirth B; Schara U; Jensen B; Becker M; Hohenfellner K; Müller-Felber W
J Neuromuscul Dis; 2019; 6(4):503-515. PubMed ID: 31594245
[TBL] [Abstract][Full Text] [Related]
13. The Carrier Frequency of Two
Davidson JE; Russell JS; Martinez NN; Mowat DR; Jones KJ; Kirk EP; Kariyawasam D; Farrar M; D'Silva A
Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510307
[TBL] [Abstract][Full Text] [Related]
14. Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening - Opportunity or Burden?
Müller-Felber W; Vill K; Schwartz O; Gläser D; Nennstiel U; Wirth B; Burggraf S; Röschinger W; Becker M; Durner J; Eggermann K; Müller C; Hannibal I; Olgemöller B; Schara U; Blaschek A; Kölbel H
J Neuromuscul Dis; 2020; 7(2):109-117. PubMed ID: 32144995
[TBL] [Abstract][Full Text] [Related]
15. Spinal Muscular Atrophy: Advanced Version of Screening System with Real-Time mCOP-PCR and PCR-RFLP for SMN1 Deletion.
Niba ETE; Rochmah MA; Harahap NIF; Awano H; Morioka I; Iijima K; Takeshima Y; Saito T; Saito K; Takeuchi A; Lai PS; Bouike Y; Matsuo M; Nishio H; Shinohara M
Kobe J Med Sci; 2019 Jul; 65(2):E49-E53. PubMed ID: 31956256
[TBL] [Abstract][Full Text] [Related]
16. Spinal muscular atrophy carriers with two SMN1 copies.
Ar Rochmah M; Awano H; Awaya T; Harahap NIF; Morisada N; Bouike Y; Saito T; Kubo Y; Saito K; Lai PS; Morioka I; Iijima K; Nishio H; Shinohara M
Brain Dev; 2017 Nov; 39(10):851-860. PubMed ID: 28676237
[TBL] [Abstract][Full Text] [Related]
17. Alberta Spinal Muscular Atrophy Newborn Screening-Results from Year 1 Pilot Project.
Niri F; Nicholls J; Baptista Wyatt K; Walker C; Price T; Kelln R; Hume S; Parboosingh J; Lilley M; Kolski H; Ridsdale R; Muranyi A; Mah JK; Bulman DE
Int J Neonatal Screen; 2023 Jul; 9(3):. PubMed ID: 37606479
[TBL] [Abstract][Full Text] [Related]
18. Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene.
Zarkov M; Stojadinović A; Sekulić S; Barjaktarović I; Perić S; Keković G; Drasković B; Stević Z
Vojnosanit Pregl; 2015 Oct; 72(10):859-63. PubMed ID: 26665550
[TBL] [Abstract][Full Text] [Related]
19. Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years.
Vill K; Schwartz O; Blaschek A; Gläser D; Nennstiel U; Wirth B; Burggraf S; Röschinger W; Becker M; Czibere L; Durner J; Eggermann K; Olgemöller B; Harms E; Schara U; Kölbel H; Müller-Felber W
Orphanet J Rare Dis; 2021 Mar; 16(1):153. PubMed ID: 33789695
[TBL] [Abstract][Full Text] [Related]
20. Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy.
Kay DM; Stevens CF; Parker A; Saavedra-Matiz CA; Sack V; Chung WK; Chiriboga CA; Engelstad K; Laureta E; Farooq O; Ciafaloni E; Lee BH; Malek S; Treidler S; Anziska Y; Delfiner L; Sakonju A; Caggana M
Genet Med; 2020 Aug; 22(8):1296-1302. PubMed ID: 32418989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
